Coaching for OCI managers and supervisors

Ended Awarded Last action

Contract number
75F40123F19295
Awardee
Awarding agency
Obligated
$62,360

Award facts

Contract value 100% obligated
$62,360.19 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
Competitive 8(a)
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 -$29,475
Original award $91,835

About this award

The Food and Drug Administration issued a BPA call to Brillient Corporation for coaching services to OCI managers and supervisors under the Professional and Technical Services Blanket Purchase Agreement, awarded June 30, 2023, with a ceiling value of $62,360.19. The call is set-aside Competitive 8(a). Place of performance is Silver Spring, Maryland. The ultimate completion date is August 25, 2026. Work is priced on a labor-hours basis. Brillient Corporation is a minority-owned Subchapter S corporation.

Quick answers

Who was awarded contract 75F40123F19295?

75F40123F19295 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on June 30, 2023.

How much is contract 75F40123F19295 worth?

The government has obligated $62,360 on 75F40123F19295.

Is contract 75F40123F19295 an order under another contract?

Yes. 75F40123F19295 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40123F19295 competed?

The extent of competition for 75F40123F19295 was full and open competition. It was set aside: Competitive 8(a).

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award